About us
E25Bio has a faster and more accurate process for identifying monoclonal antibody pairs and functionalized nanoparticles for detection of specific viruses. The improved precision allows for testing on a variety of human samples such as whole blood and nasal swabs, and that enables our rapid diagnostic tests to reach lower in the healthcare system from clinics, pharmacies, and into the home.
We aim to identify active infections in time to avoid serious complications and death. Through early and accurate screening, we help equip the right patient with the right treatment at the right time.

Meet the team
Of scientists who invented and are developing an inexpensive yet accurate means of testing for COVID-19 and the people making it happen

Prashant Chouta
CEO

Irene Bosch, PhD
Co-founder

Bobby Brooke Herrera, PhD
Co-founder & CSO

Lee Gehrke, PhD
Co-founder

Nol Salcedo, MSc
Scientist

Xiying Qu, Ph.D
Scientist

Alex Harmon
Scientist

Carlos-Henri Ferré, MA
Director of Operations and Communications

Brena Sena
Clinical Trial Lead / Regulatory Affairs Manager

Nik Lal
Design Engineer
Our investors
Without them, E25Bio wouldn’t be what it is today. So, the least we can do is to mention them.

